Skip to main content
TMDX
NASDAQ Life Sciences

Shares Surge 25% as Q3 Beat and Raised 2026 Outlook Land

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$87.77
Mkt Cap
$3.043B
52W Low
$60.105
52W High
$156
52W Position info
46% above low
Off High info
44% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

TMDX sits 46% above its 52-week low of $60.105 on elevated volume (2.2× avg).

Summary

TransMedics shares jumped more than 25% intraday, the biggest one-day gain since November 2023, after the Q3 print showed revenue of $203M (up 41% year over year) beating consensus by $25.9M and GAAP EPS of $0.46 beating by 12 cents. Operating margin of 13.9% came in 120 bps above Piper Sandler's estimate, and the beat included $9.4M of PAD Aviation charter revenue recognized for the first time after the July strategic investment. The company raised its 2026 revenue outlook to $750M-$760M from $737M-$757M, a smaller bump than the Q3 beat implies, which Piper attributed to potential October softness. Piper reaffirmed Overweight and a $100 target, pointing to an organ retrieval and clinical management service launch in Italy, the Netherlands and Belgium as the next growth driver. Note the Q3 10-Q also disclosed a material weakness in inventory-related internal controls — a risk item that has not derailed the rally but bears watching in the next quarterly filing.

At the time of this announcement, TMDX was trading at $87.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3B. The 52-week trading range was $60.11 to $156.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

TMDX - Latest Insights

TMDX
Nov 05, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $82.50
Real-time Price: $87.79 info
Change: +$5.29 (+6%) info
Market Cap: $3.06B info
TMDX
Nov 05, 2026, 4:02 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $76.80
Real-time Price: $87.79 info
Change: +$10.99 (+14%) info
Market Cap: $3.06B info
TMDX
Nov 05, 2026, 4:02 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $68.97
Real-time Price: $87.79 info
Change: +$18.82 (+27%) info
Market Cap: $3.06B info
TMDX
Aug 04, 2026, 4:44 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $88.04
Real-time Price: $87.79 info
Change: -$0.250 (-0.28%) info
Market Cap: $3.06B info
TMDX
Aug 04, 2026, 4:20 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $88.50
Real-time Price: $87.79 info
Change: -$0.710 (-0.80%) info
Market Cap: $3.06B info